Fluoroscopic-guided insertion of self-expanding metal stents for malignant gastroduodenal outlet obstruction: immediate results and clinical outcomes

Abstract

Background

Application of self-expanding metal stents (SEMS) to treat patients suffering from malignant gastroduodenal outlet obstruction (GDOO) is today considered a well-recognized palliative treatment. Use of SEMS has emerged as an attractive alternative to surgical treatment of such patients.

Purpose

To report the immediate and the mid-term clinical outcomes from a series of consecutive patients treated with exclusively fluoroscopic-guided insertion of SEMS.

Material and Methods

This was a retrospective study including patients suffering from GDOO that were either ineligible for or unwilling to undergo surgery. Patients with potentially curable disease, uncorrectable coagulopathy, gastrointestinal perforation, sepsis, presence of distal small bowel obstruction, and bowel ischemia were excluded. Technical success, clinical success, and major complications were calculated. In addition, stent migration, stent re-obstruction, restenosis, and overall re-interventions due to recurrent symptoms were considered. Kaplan-Meier survival analysis was used for patient survival estimation while both bivariable and multivariable analysis were performed to identify any independent predictors of outcomes.

Results

Fifty-one patients, (mean age, 63.73 ± 15.62 years) met the study’s criteria and were included in the final analysis. Technical and clinical success were 90.19% (n = 46/51) and 91.30% (n = 42/46), respectively. Major complications rate was 3.92%. Stent migration was noted in four cases. Restenosis and re-obstruction rates were 19.57% and 10.87%, respectively. No cases of peri-procedural mortality were noted, while Kaplan-Meier estimates for 1- and 2-year survival were 16.8% and 7.2%, respectively. Clinically successful cases and patients with primary GI tumor were related with more favorable survival compared to unsuccessful and patients suffering from GDOO due to extrinsic compression by neoplastic or lymph node disease.

Conclusion

Exclusively fluoroscopically inserted SEMS for GDOO is safe and highly effective method for palliative treatment.

Keywords

Self-expanding metal stents gastroduodenal

Get full access to this article

View all access options for this article.

References

Katsanos

Sabharwal

Adam

. Stenting of the upper gastrointestinal tract: current status. Cardiovasc Intervent Radiol 2010; 33: 690–705.

Baron

. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 2001; 344: 1681–1687.

Simmons

Baron

. Technology insight: Enteral stenting and new technology. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 365–374. 1–74.

Moura

Ferreira

Cheng

. Duodenal stenting for malignant gastric outlet obstruction: prospective study. World J Gastroenterol 2012; 18: 938–943.

Sabharwal

Irani

Adam

. Quality assurance guidelines for placement of gastroduodenal stents. Cardiovasc Intervent Radiol 2007; 30: 1–5.

Kaw

Singh

Gagneja

. Role of self-expandable metal stents in the palliation of malignant duodenal obstruction. Surg Endosc 2003; 17: 646–650.

Lopera

Brazzini

Gonzales

. Gastroduodenal stent placement: current status. Radiographics 2004; 24: 1561–1573.

Zollikofer

Jost

Schoch

. Gastrointestinal stenting. Eur Radiol 2000; 10: 329–341.

Katsanos

Ahmad

Dourado

. Interventional radiology in the elderly. Clin Interv Aging 2009; 4: 1–15.

10.

Morgan

Adam

. Use of metallic stents and balloons in the esophagus and gastrointestinal tract. J Vasc Interv Radiol 2001; 12: 283–297.

11.

Gaidos

Draganov

. Treatment of malignant gastric outlet obstruction with endoscopically placed self-expandable metal stents. World J Gastroenterol 2009; 15: 4365–4371.

12.

Wong

Brams

Munson

. Gastric outlet obstruction secondary to pancreatic cancer: surgical vs endoscopic palliation. Surg Endosc 2002; 16: 310–312.

13.

Weaver

Wiencek

Bouwman

. Gastrojejunostomy: is it helpful for patients with pancreatic cancer? Surgery 1987; 102: 608–613.

14.

Siddiqui

Spechler

Huerta

. Surgical bypass versus endoscopic stenting for malignant gastroduodenal obstruction: a decision analysis. Dig Dis Sci 2007; 52: 276–281.

15.

Del Piano

Ballare

Montino

. Endoscopy or surgery for malignant GI outlet obstruction? Gastrointest Endosc 2005; 61: 421–426.

16.

Yim

Jacobson

Saltzman

. Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endosc 2001; 53: 329–332.

17.

Johnsson

Thune

Liedman

. Palliation of malignant gastroduodenal ob1struction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation. World J Surg 2004; 28: 812–817.

18.

Doberneck

Berndt

. Delayed gastric emptying after palliative gastrojejunostomy for carcinoma of the pancreas. Arch Surg 1987; 122: 827–829.

19.

Baerlocher

Asch

Dixon

. Interdisciplinary Canadian guidelines on the use of metal stents in the gastrointestinal tract for oncological indications. Can Assoc Radiol J 2008; 59: 107–122.

20.

Kim

Choi

Lee

. Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc 2010; 72: 25–32.